Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18975323rdf:typepubmed:Citationlld:pubmed
pubmed-article:18975323lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18975323lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:18975323lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18975323lifeskim:mentionsumls-concept:C0229664lld:lifeskim
pubmed-article:18975323lifeskim:mentionsumls-concept:C0039099lld:lifeskim
pubmed-article:18975323lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:18975323lifeskim:mentionsumls-concept:C0666743lld:lifeskim
pubmed-article:18975323lifeskim:mentionsumls-concept:C1704686lld:lifeskim
pubmed-article:18975323lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:18975323pubmed:issue11lld:pubmed
pubmed-article:18975323pubmed:dateCreated2008-11-10lld:pubmed
pubmed-article:18975323pubmed:abstractTextInfliximab treatment results in a decrease in synovial cellularity as early as 48 hours after initiation of therapy in patients with rheumatoid arthritis (RA). This study was undertaken to investigate whether infliximab induces apoptosis within the first 24 hours after infusion.lld:pubmed
pubmed-article:18975323pubmed:languageenglld:pubmed
pubmed-article:18975323pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18975323pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18975323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18975323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18975323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18975323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18975323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18975323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18975323pubmed:statusMEDLINElld:pubmed
pubmed-article:18975323pubmed:monthNovlld:pubmed
pubmed-article:18975323pubmed:issn0004-3591lld:pubmed
pubmed-article:18975323pubmed:authorpubmed-author:ParrotPPlld:pubmed
pubmed-article:18975323pubmed:authorpubmed-author:BaetenDominiq...lld:pubmed
pubmed-article:18975323pubmed:authorpubmed-author:van den...lld:pubmed
pubmed-article:18975323pubmed:authorpubmed-author:Vervoordeldon...lld:pubmed
pubmed-article:18975323pubmed:authorpubmed-author:SmeetsTom JTJlld:pubmed
pubmed-article:18975323pubmed:authorpubmed-author:WoutersDianaDlld:pubmed
pubmed-article:18975323pubmed:authorpubmed-author:WijbrandtsCar...lld:pubmed
pubmed-article:18975323pubmed:authorpubmed-author:RemansPhilip...lld:pubmed
pubmed-article:18975323pubmed:authorpubmed-author:KlarenbeekPau...lld:pubmed
pubmed-article:18975323pubmed:issnTypePrintlld:pubmed
pubmed-article:18975323pubmed:volume58lld:pubmed
pubmed-article:18975323pubmed:ownerNLMlld:pubmed
pubmed-article:18975323pubmed:authorsCompleteYlld:pubmed
pubmed-article:18975323pubmed:pagination3330-9lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:meshHeadingpubmed-meshheading:18975323...lld:pubmed
pubmed-article:18975323pubmed:year2008lld:pubmed
pubmed-article:18975323pubmed:articleTitleAnalysis of apoptosis in peripheral blood and synovial tissue very early after initiation of infliximab treatment in rheumatoid arthritis patients.lld:pubmed
pubmed-article:18975323pubmed:affiliationAcademic Medical Center/University of Amsterdam, Amsterdam, The Netherlands.lld:pubmed
pubmed-article:18975323pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18975323pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18975323lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18975323lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18975323lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18975323lld:pubmed